The absence of excess mortality and a lower rate of clinically presented medullary thyroid cancer in our cohort of incidentally identified carriers unaware of their RET status perhaps suggests that some early-stage disease found through screening thyroidectomy might not progress to clinically significant disease. Here, RET is linked to medullary thyroid gland carcinoma.